Screener
Medpace Holdings, Inc. MEDP Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Operating margin | 21%-0.4pp | 21%-0.1pp | 21.1%0.0pp | 21.5%+1.8pp | 21.4%+2.6pp | |
| Net margin | 17.7%-1.1pp | 17.2%-2.1pp | 17.8%-1.3pp | 18.4%+0.7pp | 18.7%+2.0pp | |
| Returns | ||||||
| Return on equity | 162.2%+72.8pp | 77.3%+11.4pp | 70.2%+11.8pp | 73.7%+19.6pp | 89.4%+30.5pp | |
| Return on invested capital | 272.7%+154pp | 229.9%+121pp | 220%+123pp | 159.9%+84.4pp | 118.2%+51.1pp | |
| Efficiency | ||||||
| Asset turnover | 1.5×+0.3× | 1.3×+0.2× | 1.2×+0.1× | 1.2×+0.1× | 1.3×+0.1× | |
| Liquidity | ||||||
| Current ratio | 0.7×+0.3× | 0.8×+0.1× | 0.7×-0.2× | 0.6×-0.4× | 0.4×-0.5× | |
| Leverage | ||||||
| Debt-to-equity | 0.3×-0.5× | 0.2×0.0× | 0.3×+0.1× | 0.5×+0.3× | 0.9×+0.7× | |
| Net debt / EBITDA | -0.6×-0.8× | -0.9×-0.3× | -0.6×+0.5× | -0.3×+0.9× | 0.2×+1.1× | |
| Per Share | ||||||
| Book value per share | $15.19+157% | $20.66+8.6% | $15.55-39.7% | $10.19-62.9% | $5.91-75.1% | |
| Valuation | ||||||
| Market capitalization | $16.05B+31.0% | $13.63B+46.8% | $15.82B+53.2% | $14.44B+39.6% | $9.06B-28.7% | |
| Price / earnings | 32.7×+3.4× | 29.6×+7.3× | 35.1×+9.5× | 33.4×+5.1× | 21.7×-15.7× | |
| Price / sales | 5.8×+0.3× | 5.1×+0.8× | 6.3×+1.4× | 6.1×+1.1× | 4.1×-2.2× | |
| Price / book | 37×-34.1× | 22.8×+7.1× | 34.5×+22.0× | 49.2×+37.5× | 52.6×+35.9× | |
| EV / EBITDA | 25.7×+1.3× | 22.2×+3.7× | 27.5×+6.9× | 26.7×+4.2× | 18.1×-12.1× |
FAQ
- Where do Medpace Holdings, Inc.'s ratios come from?
- Every ratio is computed from Medpace Holdings, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
